DHA Shows Mixed Results In Retinitis Pigmentosa Patients – Study
This article was originally published in The Tan Sheet
Docosahexaenoic acid (DHA) supplementation does not slow the long-term development of retinitis pigmentosa (RP) in patients receiving vitamin A treatment, according to a study published in the Sept. Archives of Ophthalmology
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC